Abiopharma

🔍 Larimer David Gregory (Executive)

Company: Contango Silver & Gold Inc. (CTGO)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 5,300 shares of Common Stock, par value $0.01 (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: false | shares_owned_after: 18,093.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 9,000 shares of Stock Option (right to buy) at $18.55 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2031-04-02 | equity_swap_involved: false | shares_owned_after: 9,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: On April 2, 2026, the reporting person was granted 5,300 shares of restricted stock, which vest equally over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.
• F2: On April 2, 2026, the reporting person was granted 9,000 stock options that over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.